Inhibition of the norepinephrine transporter to treat neurogenic orthostatic hypotension: is this the end of the story?

This publication has 12 references indexed in Scilit:

• Association of transient orthostatic hypotension with falls and syncope in patients with Parkinson disease
  Neurology, 2020
• Clinical Trials for Neurogenic Orthostatic Hypotension: A Comprehensive Review of Endpoints, Pitfalls, and Challenges
  Seminars in Neurology, 2020
• Pharmacologic treatment of orthostatic hypotension
  Autonomic Neuroscience, 2020
• Impact of depressive symptoms on self-perceived severity of autonomic dysfunction in multiple system atrophy: relevance for patient-reported outcomes in clinical trials
  Clinical Autonomic Research, 2020
• Empowering phase II clinical trials to reduce phase III failures
  Pharmaceutical Statistics, 2019
• Central or peripheral autonomic dysfunction in Parkinson disease
  Neurology, 2018
• Association of Autonomic Dysfunction With Disease Progression and Survival in Parkinson Disease
  JAMA Neurology, 2017
• Efficacy of Atomoxetine Versus Midodrine for the Treatment of Orthostatic Hypotension in Autonomic Failure
  Hypertension, 2014
• Blinding in pharmacological trials: the devil is in the details
  Archives of Disease in Childhood, 2013
• Norepinephrine Transporter Blockade With Atomoxetine Induces Hypertension in Patients With Impaired Autonomic Function
  Hypertension, 2007